Below are the most recent publications written about "Prodrugs" by people in Profiles.
-
Gupta A, Maity A, Ndugire W, Chakraborty S, Ghorpade MS, Hirschbiegel CM, Ribbe A, Chakraborty A, Rotello VM. Engineered Lipid Coronas for Gold Nanoparticle-Based Bioorthogonal Catalysis. Nano Lett. 2025 07 09; 25(27):10962-10969.
-
Gupta A, Hassan MA, Ndugire W, Park J, Noor S, Nagaraj H, Chakraborty S, Rotello VM. Light-Triggered Bioorthogonal Nanozyme Hydrogels for Prodrug Activation and Treatment of Bacterial Biofilms. ACS Appl Mater Interfaces. 2025 May 07; 17(18):26361-26370.
-
Nabawy A, Gupta A, Jiang M, Hirschbiegel CM, Fedeli S, Chattopadhyay AN, Park J, Zhang X, Liu L, Rotello VM. Biodegradable nanoemulsion-based bioorthogonal nanocatalysts for intracellular generation of anticancer therapeutics. Nanoscale. 2023 Aug 25; 15(33):13595-13602.
-
Hirschbiegel CM, Zhang X, Huang R, Cicek YA, Fedeli S, Rotello VM. Inorganic nanoparticles as scaffolds for bioorthogonal catalysts. Adv Drug Deliv Rev. 2023 04; 195:114730.
-
Sugiki T, Ito A, Hatanaka Y, Tsukamoto M, Murata T, Miyanishi K, Kagawa A, Fujiwara T, Kitagawa M, Morita Y, Negoro M. Real-time monitoring of enzyme-catalyzed phosphoribosylation of anti-influenza prodrug favipiravir by time-lapse nuclear magnetic resonance spectroscopy. NMR Biomed. 2023 05; 36(5):e4888.
-
Zhang X, Lin S, Huang R, Gupta A, Fedeli S, Cao-Mil?n R, Luther DC, Liu Y, Jiang M, Li G, Rondon B, Wei H, Rotello VM. Degradable ZnS-Supported Bioorthogonal Nanozymes with Enhanced Catalytic Activity for Intracellular Activation of Therapeutics. J Am Chem Soc. 2022 07 20; 144(28):12893-12900.
-
Zhang X, Landis RF, Keshri P, Cao-Mil?n R, Luther DC, Gopalakrishnan S, Liu Y, Huang R, Li G, Malassin? M, Uddin I, Rondon B, Rotello VM. Intracellular Activation of Anticancer Therapeutics Using Polymeric Bioorthogonal Nanocatalysts. Adv Healthc Mater. 2021 03; 10(5):e2001627.
-
Kristeleit R, Evans J, Molife LR, Tunariu N, Shaw H, Slater S, Haris NRM, Brown NF, Forster MD, Diamantis N, Rulach R, Greystoke A, Asghar U, Rata M, Anderson S, Bachmann F, Hannah A, Kaindl T, Lane HA, Larger PJ, Schmitt-Hoffmann A, Engelhardt M, Tzankov A, Plummer R, Lopez J. Phase 1/2a trial of intravenous BAL101553, a novel controller of the spindle assembly checkpoint, in advanced solid tumours. Br J Cancer. 2020 10; 123(9):1360-1369.
-
Huang L, Zhao Y, Zhang H, Huang K, Yang J, Han G. Expanding Anti-Stokes Shifting in Triplet-Triplet Annihilation Upconversion for In Vivo Anticancer Prodrug Activation. Angew Chem Int Ed Engl. 2017 11 13; 56(46):14400-14404.
-
Henssen AG, Odersky A, Szymansky A, Seiler M, Althoff K, Beckers A, Speleman F, Sch?fers S, De Preter K, Astrahanseff K, Struck J, Schramm A, Eggert A, Bergmann A, Schulte JH. Targeting tachykinin receptors in neuroblastoma. Oncotarget. 2017 Jan 03; 8(1):430-443.